CLPT
Price
$16.72
Change
-$0.73 (-4.18%)
Updated
Feb 21 closing price
Capitalization
183.44M
3 days until earnings call
KRMD
Price
$3.71
Change
-$0.17 (-4.38%)
Updated
Feb 21 closing price
Capitalization
107.88M
17 days until earnings call
Ad is loading...

CLPT vs KRMD

Header iconCLPT vs KRMD Comparison
Open Charts CLPT vs KRMDBanner chart's image
ClearPoint Neuro
Price$16.72
Change-$0.73 (-4.18%)
Volume$191.34K
Capitalization183.44M
KORU Medical Systems
Price$3.71
Change-$0.17 (-4.38%)
Volume$217.56K
Capitalization107.88M
CLPT vs KRMD Comparison Chart
Loading...
CLPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLPT vs. KRMD commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLPT is a Hold and KRMD is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (CLPT: $16.72 vs. KRMD: $3.71)
Brand notoriety: CLPT and KRMD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CLPT: 95% vs. KRMD: 109%
Market capitalization -- CLPT: $183.44M vs. KRMD: $107.88M
CLPT [@Medical Specialties] is valued at $183.44M. KRMD’s [@Medical Specialties] market capitalization is $107.88M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLPT’s FA Score shows that 0 FA rating(s) are green whileKRMD’s FA Score has 0 green FA rating(s).

  • CLPT’s FA Score: 0 green, 5 red.
  • KRMD’s FA Score: 0 green, 5 red.
According to our system of comparison, KRMD is a better buy in the long-term than CLPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLPT’s TA Score shows that 4 TA indicator(s) are bullish while KRMD’s TA Score has 4 bullish TA indicator(s).

  • CLPT’s TA Score: 4 bullish, 4 bearish.
  • KRMD’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CLPT is a better buy in the short-term than KRMD.

Price Growth

CLPT (@Medical Specialties) experienced а -8.73% price change this week, while KRMD (@Medical Specialties) price change was -15.10% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.75%. For the same industry, the average monthly price growth was -1.45%, and the average quarterly price growth was +2.31%.

Reported Earning Dates

CLPT is expected to report earnings on May 13, 2025.

KRMD is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Medical Specialties (-1.75% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLPT($183M) has a higher market cap than KRMD($108M). CLPT YTD gains are higher at: 8.713 vs. KRMD (-3.636). KRMD has higher annual earnings (EBITDA): -9.4M vs. CLPT (-20.99M). CLPT has more cash in the bank: 23.1M vs. KRMD (11.5M). KRMD has less debt than CLPT: KRMD (4.45M) vs CLPT (13.9M). KRMD has higher revenues than CLPT: KRMD (28.5M) vs CLPT (24M).
CLPTKRMDCLPT / KRMD
Capitalization183M108M169%
EBITDA-20.99M-9.4M223%
Gain YTD8.713-3.636-240%
P/E RatioN/AN/A-
Revenue24M28.5M84%
Total Cash23.1M11.5M201%
Total Debt13.9M4.45M313%
FUNDAMENTALS RATINGS
CLPT vs KRMD: Fundamental Ratings
CLPT
KRMD
OUTLOOK RATING
1..100
992
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
93
Overvalued
PROFIT vs RISK RATING
1..100
57100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
3840
P/E GROWTH RATING
1..100
10047
SEASONALITY SCORE
1..100
n/a47

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLPT's Valuation (53) in the null industry is somewhat better than the same rating for KRMD (93). This means that CLPT’s stock grew somewhat faster than KRMD’s over the last 12 months.

CLPT's Profit vs Risk Rating (57) in the null industry is somewhat better than the same rating for KRMD (100). This means that CLPT’s stock grew somewhat faster than KRMD’s over the last 12 months.

CLPT's SMR Rating (97) in the null industry is in the same range as KRMD (97). This means that CLPT’s stock grew similarly to KRMD’s over the last 12 months.

CLPT's Price Growth Rating (38) in the null industry is in the same range as KRMD (40). This means that CLPT’s stock grew similarly to KRMD’s over the last 12 months.

KRMD's P/E Growth Rating (47) in the null industry is somewhat better than the same rating for CLPT (100). This means that KRMD’s stock grew somewhat faster than CLPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLPTKRMD
RSI
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 19 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
78%
View a ticker or compare two or three
Ad is loading...
CLPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSIRX12.80-0.05
-0.39%
Victory RS International R6
JFNNX71.42-0.51
-0.71%
Janus Henderson Global Life Sciences N
LRAGX14.84-0.17
-1.13%
Lord Abbett International Growth R3
HSMVX13.15-0.26
-1.94%
Hartford Small Cap Value R6
USTCX28.73-0.87
-2.94%
Victory Science & Technology Class A

KRMD and

Correlation & Price change

A.I.dvisor tells us that KRMD and NVST have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KRMD and NVST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRMD
1D Price
Change %
KRMD100%
-4.38%
NVST - KRMD
29%
Poorly correlated
-2.70%
MASS - KRMD
29%
Poorly correlated
-6.99%
CLPT - KRMD
28%
Poorly correlated
-4.18%
ARAY - KRMD
28%
Poorly correlated
-2.31%
OM - KRMD
26%
Poorly correlated
-8.81%
More